Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.72 BRL | -0.56% |
|
-.--% | -10.95% |
Jul. 10 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
Jul. 09 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
Performance
1 day | -0.56% | ||
3 months | -0.56% | ||
6 months | -10.95% | ||
Current year | -10.95% | ||
1 year | -4.75% |
Volumes
marketsBasic data
Highs and lows
![Extreme 38.72](/images/extremecours_fleche.png)
![Extreme 38.72](/images/extremecours_fleche.png)
![Extreme 38.72](/images/extremecours_fleche.png)
![Extreme 38.72](/images/extremecours_fleche.png)
![Extreme 38.72](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.56% | -.--% | -10.95% | -4.75% | 6.66B | ||
+0.22% | +3.54% | +63.05% | +111.47% | 854B | ||
-0.71% | -1.15% | +39.42% | +83.05% | 636B | ||
-0.43% | +2.58% | -4.78% | -6.65% | 361B | ||
+0.28% | +1.86% | +17.52% | +19.36% | 324B | ||
-0.41% | +0.91% | +8.43% | +23.54% | 301B | ||
-1.27% | +0.50% | +14.19% | +17.24% | 247B | ||
+1.53% | +6.16% | +5.81% | -4.61% | 230B | ||
-0.96% | +1.93% | +16.77% | +16.64% | 228B | ||
-0.21% | +6.00% | +14.63% | +45.17% | 177B | ||
+0.62% | +4.19% | +1.08% | -19.88% | 164B | ||
-2.09% | +0.36% | +2.97% | -1.36% | 129B | ||
+1.21% | +4.83% | -12.59% | -8.27% | 87.16B | ||
-0.77% | +0.40% | -21.75% | -35.18% | 82.02B | ||
+0.70% | +2.60% | +55.73% | +54.50% | 72.4B | ||
-2.24% | -2.27% | +15.01% | +57.22% | 65.49B | ||
Average | -0.34% | +2.64% | +12.78% | +21.72% | ||
Weighted average by Cap. | -0.23% | +2.50% | +25.04% | +44.04% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -10.95% | ||
2023 | -22.36% | ||
2022 | +13.23% |
- Stock Market
- Equities
- JAZZ Stock
- J2AZ34 Stock
- Quotes Jazz Pharmaceuticals plc